While its role in tumor progression is still underexplored, a recent study revealed that ARPP19 mRNA expression is an independent predictor for relapse in AML, and it might promote cell survival by regulating CIP2A and MYC expression [100]. This evidence concerns the gene CIP2A and acute myeloid leukemia.